Edition:
United States

Insider Trading: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,445JPY
2:00am EDT
Change (% chg)

¥-16 (-1.06%)
Prev Close
¥1,460
Open
¥1,466
Day's High
¥1,474
Day's Low
¥1,444
Volume
8,469,000
Avg. Vol
7,419,461
52-wk High
¥1,688
52-wk Low
¥1,332

All Insider Trades

Institutional Holders

% Shares Owned: 59.07%
# of Holders: 461
Total Shares Held: 1,222,015,150
3 Mo. Net Change: 3,166,832
# New Positions: 9
# Closed Positions: 19
# Increased Positions: 127
# Reduced Positions: 119
# Net Buyers: 8

Officers & Directors

Name Age Since Current Position

Yoshihiko Hatanaka

60 2017 President, Chief Executive Officer, Representative Director

Chikashi Takeda

2017 Chief Financial Officer, Executive Officer

Fumiaki Sakurai

2017 Chief Administrative Officer, Chief Ethics & Compliance Officer, Executive Officer

Kenji Yasukawa

57 2017 Vice President, Chief Strategy Officer, Chief Commercial Officer, Representative Director

Linda Friedman

2017 General Counsel

Masatoshi Kuroda

2017 Senior Executive Officer, Chief Director of Asia & Oceania Business

Mitsunori Matsuda

2017 Senior Executive Officer, Chief Director of Pharmaceutical Technology

Makoto Takeuchi

2015 Senior Executive Officer, Director of External Affairs

Wataru Uchida

2015 Senior Executive Officer, Chief Director of Research

Chihiro Yokota

2015 Senior Executive Officer, Chief Director of Development

Nobuaki Tanaka

2016 Executive Officer, Chief Director of Sales

Tadashi Hara

2017 Executive Officer, Director of Sales Strategy in Main Sales Unit

Akihiko Iwai

2017 Executive Officer, Director of Candidate Discovery Research Institute in Main Research Unit

Atsushi Kamide

2016 Executive Officer, Director of Health Policy

Yasuhiro Kanzaki

2016 Executive Officer, Manager of Osaka Office in Main Sales Unit

Yukio Matsui

2016 Executive Officer, Manager of Europe & Middle East & Africa Business

Eisuke Nozawa

Executive Officer, Director of Pharmaceutical Affairs

Naoki Okamura

2016 Executive Officer, Director of Business Planning

Kazunori Okimura

2016 Executive Officer, Director of Legal Affairs

Takuya Oshida

2016 Executive Officer, Chief Director of Medical Affairs

Katzumi Ozawa

Executive Officer, Manager of Tokyo Office in Main Sales Unit

Kazuhiro Sako

Executive Officer, President of Subsidiary

Taiji Sawamoto

2017 Executive Officer, Director of Research Program Promotion in Main Research Unit

Hideki Shima

2017 Executive Officer, Director of Technology Planning in Main Pharmaceutical Technology Unit

Shigeki Tanaka

2017 Executive Officer, Director of 1st Japan & Asia Clinical Development in Main Development Unit

Toru Yoshimitsu

2017 Executive Officer, Director of Business Promotion

Sef Kurstjens

2017 Chief Medical Officer

Yoshiharu Aizawa

71 2015 Independent Director

Etsuko Okajima

51 2014 Independent Director

Mamoru Sekiyama

67 2017 Independent Director

Keiko Yamagami

56 2017 Independent Director

Akira Kamimura

2017 Director of Accounting